Dr. Kelley O’Donnell is a board-certified psychiatrist and a psychedelic clinician-researcher in New York City.
Her private practice is located in Manhattan, adjacent to Madison Square Park.
Kelley is an Assistant Professor of Psychiatry at the NYU Grossman School of Medicine, where she is the Director of Clinical Training at the NYU Langone Center for Psychedelic Medicine. She is a lead therapist, co-investigator, and clinical supervisor on a number of trials of psychedelic-assisted psychotherapy (including psilocybin and MDMA) for a variety of therapeutic applications. Outside NYU, she is a Lead Educator and Clinical Consultant in the Lykos Therapeutics (formerly MAPS-Public Benefit Corporation) MDMA Therapist Education Program, and she is on the faculty of the psychedelic therapist training programs at the Polaris Insight Center and the Integrative Psychiatry Institute.
As an undergraduate, Kelley was in the Great Books program at St. John’s College. After completing post-baccalaureate premedical coursework, she conducted research at the National Institute of Mental Health before earning her MD and PhD (Neuroscience) degrees in the Medical Scientist Training Program at UCLA. Kelley completed her residency in Adult Psychiatry at the NYU School of Medicine. In addition to conventional psychiatry training, she completed a Fellowship in Psychoanalysis at both Columbia University and the Psychoanalytic Association of New York (PANY), and became certified as an MDMA therapist (MAPS-PBC), ketamine therapist (KTC), and psychedelic therapist (IPI). She has co-authored over 20 peer-reviewed journal articles, and has received a number of awards for both research and clinical excellence, including the prestigious NIMH Outstanding Resident Award and the ADAA Career Development Leadership Award.